Embedding European Pharmacopoeia mRNA Standards into CMC & Process Strategies to Ensure Harmonised Quality

  • Adapting test methods, acceptance criteria and reference standards to meet European Pharmacopoeia expectations without overburdening development resources
  • Assessing how evolving European Pharmacopoeia content interacts with MHRA, EMA and other agency expectations to build a coherent, Europe-ready CMC framework